We could not establish in this study any different sensitivity to α-BSB related to clinical stage according to Binet or to biological characteristics of B-CLL cells (i.e. CD38 positivity, IgVH mutational state or chromosomal abnormalities). The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.